Gavi, the Vaccine Alliance today announced a series of new partnerships with leading global businesses, brands and philanthropic organisations aimed at accelerating innovation and expanding access to vaccines and primary health care for underserved communities.

“Gavi was created as a public-private partnership, and that model is more relevant than ever in today’s global health landscape,” said Dr Sania Nishtar, CEO of Gavi, the Vaccine Alliance. “By combining innovation with strong new partnerships and the support of donors and governments, Gavi is helping countries move proven solutions beyond the pilot phase and into national systems at scale.”

The Gavi Innovation Scale-Up Facility (SUF): first announced at Gavi’s replenishment Summit in June 2025, the Scale-Up Facility is a unique mechanism designed to unlock private capital and scale-up proven innovations already in use across the immunisation value chain. It works by matching donors and investors with innovations that countries have successfully piloted and are looking to deploy more widely. Building on the anchor pledge of up to CAD 40 million made by Grand Challenges Canada (GCC) in June, this week Gavi announces that 500 Global intends to partner with Gavi and GCC to advance shared goals of sustainable scaling of innovations through the Scale-Up Facility. Together, Gavi, GCC and 500 Global aim to mobilise up to US$ 300 million for the SUF to accelerate the scaling of high-impact innovations.

"At the heart of this work is one mission: saving lives and turning innovations into lasting change. By partnering with Gavi, Grand Challenges Canada, and other collaborators, we can reach those who are most underserved, and by aligning partners to absorb different risks, we can deploy capital more efficiently and scale proven solutions in fragile and emerging settings. Strategic risk-taking can unlock transformative health outcomes, and we invite others to join this vital work," Dr Alaa Murabit, Managing Partner, Sustainability Growth, 500 Global